UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: InfluvacTetra-0.5ml-Suspension-SE-AJ-RA

Generated Narrative: RegulatedAuthorization InfluvacTetra-0.5ml-Suspension-SE-AJ-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/55200

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002180-00055200,http://ema.europa.eu/fhir/eurdId#1744; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Suspension for injection in pre-filled syringe; indication = Influensaprofylax, speciellt för dem som löper ökad risk för influensarelaterade komplikationer. Influvac Tetra är indicerat för vuxna och barn från 6 månaders ålder. Användningen av Influvac Tetra ska bedömas på basis av officiella rekommendationer.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = influenza, inactivated, split virus or surface antigen

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2017-11-17

holder: Organization BGP Products AB

Cases

-TypeDate[x]
*First Authorisation2017-11-17